Lateral Canthal Lines (LCL)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Lateral Canthal Lines (LCL) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07492277

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

This study will serve to collect and analyze additional data on the use of the device croma revitalis for treatment of fine lines on the face including LCL and…

Austria70 participantsStarted 2026-01-16

All recent trials (9 shown)

Not Yet RecruitingPhase 4

NCT07388927

A Real-World Study on Effect of Hirudoid on Ecchymosis After Treatment of Crow's Feet With Botulinum Toxin Type A

Botulinum toxin type A (commonly referred to as 'Botox') injections are a treatment that dermatologists regularly use to smoothen wrinkles such as 'Crow's feet'…

Location not specified48 participantsStarted 2026-02

Treatment: Hirudoid (heparinoids) ointment, 3mg/g

CompletedPhase 2

NCT04985916

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

United States280 participantsStarted 2021-07-19

Treatment: Vehicle, botulinum toxin, Type A

Lateral Canthal Lines (LCL)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

All recent trials (9 shown)

A Real-World Study on Effect of Hirudoid on Ecchymosis After Treatment of Crow's Feet With Botulinum Toxin Type A

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

All recent trials (9 shown)

A Real-World Study on Effect of Hirudoid on Ecchymosis After Treatment of Crow's Feet With Botulinum Toxin Type A

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Mo…

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines

MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)

ET-01 in Subjects With Lateral Canthal Lines, LCL-209